Search research articles
Contact Us
Filters
Showing results (291-300 of 365) with videos related to
Page
of 37
Sort By:
Alimentary Pharmacology & Therapeutics
|
October 25, 2018
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Biomarker Research
|
November 19, 2025
Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis
Stephania C Isaza, Carlos Ernesto Fernández-García, Diego Rojo, et al.
Hepatology (Baltimore, Md.)
|
December 31, 2016
Deregulated neddylation in liver fibrosis
Imanol Zubiete-Franco, Pablo Fernández-Tussy, Lucía Barbier-Torres, et al.
Medicina Clinica
|
March 11, 2017
Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers
Carlos Rodríguez de Lope, María Reig, Ana Matilla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 6, 2022
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors
Juan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, et al.
Plos One
|
March 21, 2017
A morphological method for ammonia detection in liver
Virginia Gutiérrez-de-Juan, Sergio López de Davalillo, David Fernández-Ramos, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2024
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia
Marta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Gastroenterologia Y Hepatologia
|
October 10, 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Javier Crespo, Agustín Albillos, María Buti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practice
Antonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Page
of 37
Search research articles
Search
Showing results (291-300 of 365) with videos related to
Sort By:
Page
of 37
Alimentary Pharmacology & Therapeutics
|
October 25, 2018
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Biomarker Research
|
November 19, 2025
Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis
Stephania C Isaza, Carlos Ernesto Fernández-García, Diego Rojo, et al.
Hepatology (Baltimore, Md.)
|
December 31, 2016
Deregulated neddylation in liver fibrosis
Imanol Zubiete-Franco, Pablo Fernández-Tussy, Lucía Barbier-Torres, et al.
Medicina Clinica
|
March 11, 2017
Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers
Carlos Rodríguez de Lope, María Reig, Ana Matilla, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 6, 2022
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors
Juan Carlos Rodriguez-Duque, José Luis Calleja, Paula Iruzubieta, et al.
Plos One
|
March 21, 2017
A morphological method for ammonia detection in liver
Virginia Gutiérrez-de-Juan, Sergio López de Davalillo, David Fernández-Ramos, et al.
Hepatology (Baltimore, Md.)
|
September 26, 2024
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Mazen Noureddin, Emily Truong, Rebeca Mayo, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2022
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia
Marta Alonso-Peña, Ricardo Espinosa-Escudero, Elisa Herraez, et al.
Gastroenterologia Y Hepatologia
|
October 10, 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Javier Crespo, Agustín Albillos, María Buti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practice
Antonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Page
of 37